CS182781B2 - Method of producing 2,6-diaminodihydropyridines - Google Patents

Method of producing 2,6-diaminodihydropyridines

Info

Publication number
CS182781B2
CS182781B2 CS7300001593A CS159373A CS182781B2 CS 182781 B2 CS182781 B2 CS 182781B2 CS 7300001593 A CS7300001593 A CS 7300001593A CS 159373 A CS159373 A CS 159373A CS 182781 B2 CS182781 B2 CS 182781B2
Authority
CS
Czechoslovakia
Prior art keywords
diaminodihydropyridines
producing
Prior art date
Application number
CS7300001593A
Other languages
Czech (cs)
English (en)
Inventor
Horst Meyer
Kurt Stoepel
Wulf Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CS182781B2 publication Critical patent/CS182781B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CS7300001593A 1972-03-06 1973-03-06 Method of producing 2,6-diaminodihydropyridines CS182781B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CS182781B2 true CS182781B2 (en) 1978-05-31

Family

ID=5838037

Family Applications (2)

Application Number Title Priority Date Filing Date
CS7300001593A CS182781B2 (en) 1972-03-06 1973-03-06 Method of producing 2,6-diaminodihydropyridines
CS7500003602A CS182792B2 (en) 1972-03-06 1973-03-06 Method of production of 2,6-diaminodihydropyridines

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS7500003602A CS182792B2 (en) 1972-03-06 1973-03-06 Method of production of 2,6-diaminodihydropyridines

Country Status (24)

Country Link
JP (2) JPS5626659B2 (ja)
KR (1) KR780000119B1 (ja)
AT (3) AT324338B (ja)
BE (1) BE796279A (ja)
BG (2) BG22815A3 (ja)
CA (1) CA988524A (ja)
CH (2) CH577473A5 (ja)
CS (2) CS182781B2 (ja)
DD (1) DD106833A5 (ja)
DE (1) DE2210687C3 (ja)
DK (1) DK136061C (ja)
ES (1) ES412323A1 (ja)
FI (1) FI55996C (ja)
FR (1) FR2181789B1 (ja)
GB (1) GB1379005A (ja)
HU (1) HU167089B (ja)
IE (1) IE37370B1 (ja)
IL (1) IL41664A (ja)
LU (1) LU67147A1 (ja)
NL (1) NL7303137A (ja)
PL (2) PL92078B1 (ja)
RO (2) RO63068A (ja)
SE (1) SE384208B (ja)
ZA (1) ZA731501B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (ja) * 1985-11-28 1987-06-13
AU2021387535A1 (en) * 2020-11-30 2023-07-06 George Kanianthara Chandy POTENT AND SELECTIVE INHIBITORS OF THE CALCIUM-ACTIVATED POTASSIUM CHANNEL, KCa3.1, FOR USE AS PLATFORM THERAPEUTICS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
DK136061B (da) 1977-08-08
JPS48103579A (ja) 1973-12-25
FR2181789A1 (ja) 1973-12-07
FI55996B (fi) 1979-07-31
FR2181789B1 (ja) 1976-12-03
ZA731501B (en) 1973-11-28
AT324338B (de) 1975-08-25
JPS5911584B2 (ja) 1984-03-16
CA988524A (en) 1976-05-04
RO61192A (ja) 1976-09-15
BE796279A (fr) 1973-09-05
CS182792B2 (en) 1978-05-31
JPS5626659B2 (ja) 1981-06-19
LU67147A1 (ja) 1973-05-22
GB1379005A (en) 1975-01-02
DE2210687A1 (de) 1973-09-20
IE37370B1 (en) 1977-07-06
RO63068A (ja) 1978-05-15
DE2210687C3 (de) 1981-09-24
CH580589A5 (ja) 1976-10-15
NL7303137A (ja) 1973-09-10
ES412323A1 (es) 1976-01-01
IL41664A0 (en) 1973-05-31
AT327904B (de) 1976-02-25
DK136061C (da) 1978-01-02
BG20583A3 (bg) 1975-12-05
BG22815A3 (bg) 1977-04-20
IE37370L (en) 1973-09-06
DD106833A5 (ja) 1974-07-05
CH577473A5 (ja) 1976-07-15
JPS5699460A (en) 1981-08-10
KR780000119B1 (en) 1978-04-15
IL41664A (en) 1976-01-30
SE384208B (sv) 1976-04-26
HU167089B (ja) 1975-08-28
ATA925774A (de) 1975-05-15
FI55996C (fi) 1979-11-12
PL89256B1 (ja) 1976-11-30
DE2210687B2 (de) 1980-09-04
PL92078B1 (ja) 1977-03-31

Similar Documents

Publication Publication Date Title
CS183675B2 (en) Method of producing new benzo-1,2,4-triazin-di-n-oxides/1,4/
CS183722B2 (en) Method for producing 3-hydroxycephalosporines
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS182260B2 (en) Method of producing 1,3-oxidated 8alfa-estratrienes
CS171232B2 (en) Method of 2,2-diaryl-4-(4'-aryl-4'-hydroxypiperidino) butyramides production
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
CS182248B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
CA1008847A (en) Method of producing dl-methionyl-dl-methionine
GB1320984A (en) Method of producing 1,3-bis-hydroxyaryl tetraorganodisolaxanes
CS182792B2 (en) Method of production of 2,6-diaminodihydropyridines
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
CS184329B2 (en) Method for producing pure 1-nitroantraquionone
CS183691B2 (en) Method for producing alkylsulphobenzylpenicillins
HU170929B (hu) Sposob poluchenija novykh 2-beta-gidroksi-3-al'fa-amino-steroidov i roizvodnykh
CS193475B2 (en) Method of producing derivatives of 2beta,16 beta-bispiperazino-andrestane
CS188175B2 (en) Method of producing 15-substituted omega-nor-prostaglandins
CS181731B2 (en) Method of producing new derivatives of 2,10-dichlor-12h-dibenzo/d,g//1,3/dioxocine
CS193477B2 (en) Method of producing 15 alpha,16 alpha-methylene-4-pregnenes
CS181221B2 (en) Method of producing 2,4-diamino-5-/3,4,5-triethoxybenzyl/-pyrimidine
JPS51125018A (en) Method of producing teromerized polyamide
CS193022B2 (en) Method of producing derivatives of phosphonourea or phosphonothiourea
CS179035B1 (en) Method for production of 2',3'-didesoxy-3'-fluorpyrimidine-nucleosides
CS186254B2 (en) Method for producing aminoderivatives of 2,2-diaryl cyclopropane
CS193019B2 (en) Method of producing 15alpha-methylene-4-estrene-17beta-ols